News
Meet DoubleBlind, The New Magazine Focused On Psychedelics
The psychedelics market is growing, as more jurisdictions legalize or decriminalize different form of them. In this context, Shelby Hartman and Madison Margolin are launching DoubleBlind, a biannual print magazine and digital media company focused on psychedelics....
AOC Says She’ll Introduce More Psychedelics Legislation In Congress
Rep. Alexandria Ocasio-Cortez (D-NY) said she supports the national movement to decriminalize psychedelics and plans to again introduce legislation promoting research into such substances, according to an activist who spoke with her following a town hall meeting on...
Scientists studying psychoactive drugs accidentally proved the self is an illusion
A glimpse of truth Philosophers and mystics have long contemplated the disconcerting notion that the fixed self is an illusion. Neuroscientists now think they can prove it or, at least, help us glimpse this truth with some help from psilocybin, the psychoactive...
Psychedelics Help You Become Emotionally Adaptable, Study Finds
Recent studies have found that psychedelics could provide answers for multiple psychiatric disorders, with significant results in combatting treatment-resistant anxiety and depression. A systematic review of previous studies showed that administering psychedelics...
Can magic mushrooms and LSD treat depression and anxiety? Scientists are optimistic.
When Marc Morgan tried lysergic acid diethylamide, better known as LSD or acid, for the first time as a teenager, he noticed that he could emotionally disconnect from traumatic memories of the sexual abuse he had suffered as a child. “It allowed me to dissociate from...
The growing push for medical use of psilocybin in Canada
TORONTO — Growing evidence about the powers of psilocybin, a naturally occurring psychedelic compound produced by several species of mushrooms, being used to treat anxiety and depression has inspired advocates to file a federal court challenge next month to allow its...
A step closer to legalizing magic mushrooms as FDA lets second research group use the ‘breakthrough’ drug in clinical trial to treat 80 patients with depression
FDA official designated Ursona Institute’s phase 2 clinical trials using psilocybin to treat depression in 80 patients Breakthrough Therapy status Wednesday The psychoactive chemical comes from ‘magic mushrooms’ and has now been given ‘Breakthrough Therapy’...
‘Magic mushroom’ ingredient could be used to treat depression, study says
LONDON - JULY 18: Mushrooms lay in a fridge on July 18. 2005 in London, England. The sale of fresh mushrooms has been prohibited as of today due to the reclassification of the drug to Class A. (Photo by Daniel Berehulak/Getty Images) More than 264 million people...
Yale Research Confirms Lingering Mood Benefit of Psychedelics Like LSD and Magic Mushrooms
The research team found that people who recently took psychedelics such as LSD and psilocybin, more commonly known as magic mushrooms, were more likely to report having “transformative experiences” so profound that they came out of the experience radically changed....